Our website uses cookies to enable essential features and improve your browsing experience. Additionally, cookies enhance overall website functionality and user experience. By choosing I Accept, you agree to our use of non-essential cookies and other tracking technologies.

You have the ability to manage your settings or withdraw your consent at any time. We are committed to maintaining the privacy and security of your personal information. For detailed information on how we use cookies, including how to manage your privacy and preferences, please visit our cookie policy .
Developmentaid logo
Register
Print
Print
European Investment Bank (HQ)

Alfasigma Innovative Drugs Rdi II

Last update: 4 days ago Last update: Jul 3, 2025

Details

Location:Italy
Italy
Status:Approval
Sectors:Health
Languages:English
Contracting authority: Alfasigma S.p.a ( Sigma Tau Industrie Farmaceutiche Riunite SpA)
Funding Agency:
European Investment Bank (HQ)
Contracting authority type:Supplier / manufacturer
Eligibility:Unknown
Budget: EUR 613,000,000
Date posted: Jul 3, 2025

Attachments • 0

Associated Awards

Project cycle timeline

STAGES
EARLY INTELLIGENCE
PROCUREMENT
IMPLEMENTATION
Cancelled
Status
Programming
Formulation
Approval
Forecast
Open
Closed
Shortlisted
Awarded
Evaluation

Description

ALFASIGMA INNOVATIVE DRUGS RDI II Reference: 20240568 Release date: 3 July 2025 Promoter – Financial IntermediaryALFASIGMA SPA LocationItaly DescriptionThe project will finance the Promoter's research, development and innovation (RDI) activities 2025-2027
Want to unlock full information?
Member-only information. Become a member to access this information. Procurement notices from over 112+ donors and banks are available here
Learn more about our membership benefits
Print